The 21 references in paper A. Ignatova V., A. Stroganova M., S. Dranko L., A. Senderovich I., S. Podvyaznikov O., А. Игнатова В., А. Строганова М., С. Дранко Л., А. Сендерович И., С. Подвязников О. (2017) “Особенности мутаций в генах KIT, NRAS и BRAF при меланоме слизистых оболочек верхних дыхательно-пищеварительных путей (исследование с участием 21 пациента) // KIT, NRAS and BRAF mutations in head and neck (upper aerodigestive tract) mucosal melanoma (a study of 21 cases)” / spz:neicon:ogsh:y:2017:i:1:p:69-74

1
Weber C.O. Surgical experience and research, in addition to interesting observations from the Surgical Clinic and the Protestant Hospital Bonn. Berlin, Germany: G. Reimer, 1859. Р. 304–5.
(check this in PDF content)
2
Manolidis S., Donald P.J. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer 1997;80:1373–86. PMID: 9338460.
(check this in PDF content)
3
Lourenço S.V., Sangueza M., Sotto M.N. et al. Primary oral mucosal melanoma: a series of 35 new cases from South America. Am J Dermatopathol 2009;31:323–30. DOI: 10.1097/DAD.0b013e3181a0d37c. PMID: 19461235.
(check this in PDF content)
4
Anderson L.J., Berthelsen A., Hansen H.S. Malignant melanoma of the upper respiratory tract and the oral cavity. J Otolaryngol 1992;21:180–5.
(check this in PDF content)
5
Thompson L.D., Wieneke J.A., Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594–611. PMID: 12717245.
(check this in PDF content)
6
Patel S.G., Prasad M.L., Escrig M. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002;24:247–57. PMID: 11891956.
(check this in PDF content)
7
Owens J.M., Roberts D.B., Myers J.N. The role of postoperative adjuvantradiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 2003;129:864–8. DOI: 10.1001/archotol.129.8.864. PMID: 12925346.
(check this in PDF content)
8
Gorsky M., Epstein J.B. Melanoma arising from the mucosal surfaces of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:715–9. PMID: 9868730.
(check this in PDF content)
9
Trap T.K., Fu Y., Calcaterra T.C. Melanoma of the nasal and paranasal sinus mucosa. Arch Otolaryngol Head Neck Surg 1987;113(10):1086– 9. PMID: 3620131.
(check this in PDF content)
10
Papaspyrou G., Garbe C., Schadendorf D. et al. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res 2011;21: 475–82. DOI: 10.1097/CMR.0b013e32834b58cf. PMID: 21897303.
(check this in PDF content)
11
Davies H., Bignell G.R., Cox C. et al. Mutations of the BRAF gene in human cancer. Nature 2002;417(6892):949–54. DOI: 10.1038/nature00766. PMID: 12068308.
(check this in PDF content)
12
Omholt K., Grafström E., KanterLewensohn L. et al. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res 2011;17:3933–42. DOI: 10.1158/1078-0432.CCR-10-2917. PMID: 21680547.
(check this in PDF content)
13
Carvajal R.D., Spencer S.A., Lydiatt W. Mucosal melanoma: a clinically and biologically unique disease entity. J Natl Compr Cancer Netw 2012;10(3):345–56. PMID: 22393195.
(check this in PDF content)
14
Turri-Zanoni M., Medicina D., Lombardi D. et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck 2013;35:1066–77. DOI: 10.1002/hed.23079. PMID: 22791410.
(check this in PDF content)
15
Ascierto P.A., Minor D., Ribas A. et al. Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma. J Clin Oncol 2013;31(26):3205–11. DOI: 10.1200/JCO.2013.49.8691. PMID: 23918947.
(check this in PDF content)
16
Chapman P.B., Hauschild A., Robert C. et al. (BRIM-3 Study Group.). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364(26):2507–16. DOI: 10.1056/NEJMoa1103782. PMID: 21639808.
(check this in PDF content)
17
Zebary A., Jangard M., Omholt K. et al. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases: British Journal of Cancer 2013;109:559–64. DOI: 10.1038/bjc.2013.373. PMID: 23860532.
(check this in PDF content)
18
Gorden A., Osman I., Gai W. et al. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer research 2003;63(14):3955–7. PMID: 12873990.
(check this in PDF content)
19
Wilson M.A., Zhao F., Letrero R. et al. Correlation of somatic mutations and clini cal outcome in melanoma patients treated with Carboplatin, Paclitaxel, and sorafenib. Clin Cancer Res
(check this in PDF content)
20
4;20(12):3328–37. DOI: 10.1158/1078-0432.CCR-14-0093. PMID: 24714776. 20. Beadling C., Jacobson-Dunlop E., Hodi F.S. et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008;14:6821–8. DOI: 10.1158/1078-0432.CCR-08-0575. PMID: 18980976.
(check this in PDF content)
21
Schoenewolf N.L., Bull C., Belloni B. et al. Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations. Eur J Cancer 2012;48:
(check this in PDF content)